nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—KDR—hindlimb—abdominal aortic aneurysm	0.0294	0.058	CbGeAlD
Ponatinib—LYN—blood plasma—abdominal aortic aneurysm	0.0265	0.0523	CbGeAlD
Ponatinib—BCR—blood plasma—abdominal aortic aneurysm	0.0228	0.045	CbGeAlD
Ponatinib—FLT3—blood plasma—abdominal aortic aneurysm	0.0226	0.0447	CbGeAlD
Ponatinib—TEK—artery—abdominal aortic aneurysm	0.022	0.0435	CbGeAlD
Ponatinib—FGFR4—connective tissue—abdominal aortic aneurysm	0.0205	0.0406	CbGeAlD
Ponatinib—SRC—artery—abdominal aortic aneurysm	0.0196	0.0387	CbGeAlD
Ponatinib—KDR—artery—abdominal aortic aneurysm	0.018	0.0356	CbGeAlD
Ponatinib—FGFR4—kidney—abdominal aortic aneurysm	0.0175	0.0346	CbGeAlD
Ponatinib—SRC—blood plasma—abdominal aortic aneurysm	0.0147	0.029	CbGeAlD
Ponatinib—LYN—connective tissue—abdominal aortic aneurysm	0.0141	0.0278	CbGeAlD
Ponatinib—FGFR3—connective tissue—abdominal aortic aneurysm	0.014	0.0277	CbGeAlD
Ponatinib—KDR—blood plasma—abdominal aortic aneurysm	0.0135	0.0267	CbGeAlD
Ponatinib—FLT3—connective tissue—abdominal aortic aneurysm	0.012	0.0238	CbGeAlD
Ponatinib—KIT—blood plasma—abdominal aortic aneurysm	0.012	0.0236	CbGeAlD
Ponatinib—FGFR3—kidney—abdominal aortic aneurysm	0.0119	0.0236	CbGeAlD
Ponatinib—RET—connective tissue—abdominal aortic aneurysm	0.00966	0.0191	CbGeAlD
Ponatinib—FGFR3—spinal cord—abdominal aortic aneurysm	0.00929	0.0184	CbGeAlD
Ponatinib—FGFR2—connective tissue—abdominal aortic aneurysm	0.00917	0.0181	CbGeAlD
Ponatinib—TEK—connective tissue—abdominal aortic aneurysm	0.0088	0.0174	CbGeAlD
Ponatinib—RET—kidney—abdominal aortic aneurysm	0.00822	0.0162	CbGeAlD
Ponatinib—BCR—spinal cord—abdominal aortic aneurysm	0.00804	0.0159	CbGeAlD
Ponatinib—PDGFRA—connective tissue—abdominal aortic aneurysm	0.00797	0.0157	CbGeAlD
Ponatinib—SRC—connective tissue—abdominal aortic aneurysm	0.00781	0.0154	CbGeAlD
Ponatinib—FGFR2—kidney—abdominal aortic aneurysm	0.00781	0.0154	CbGeAlD
Ponatinib—TEK—kidney—abdominal aortic aneurysm	0.00749	0.0148	CbGeAlD
Ponatinib—KDR—connective tissue—abdominal aortic aneurysm	0.00719	0.0142	CbGeAlD
Ponatinib—FGFR1—spinal cord—abdominal aortic aneurysm	0.00715	0.0141	CbGeAlD
Ponatinib—CYP2C8—blood plasma—abdominal aortic aneurysm	0.00676	0.0134	CbGeAlD
Ponatinib—SRC—kidney—abdominal aortic aneurysm	0.00665	0.0131	CbGeAlD
Ponatinib—RET—spinal cord—abdominal aortic aneurysm	0.0064	0.0127	CbGeAlD
Ponatinib—KIT—connective tissue—abdominal aortic aneurysm	0.00637	0.0126	CbGeAlD
Ponatinib—KDR—kidney—abdominal aortic aneurysm	0.00612	0.0121	CbGeAlD
Ponatinib—CYP3A5—blood plasma—abdominal aortic aneurysm	0.0061	0.0121	CbGeAlD
Ponatinib—FGFR2—spinal cord—abdominal aortic aneurysm	0.00608	0.012	CbGeAlD
Ponatinib—TEK—spinal cord—abdominal aortic aneurysm	0.00583	0.0115	CbGeAlD
Ponatinib—ABL1—connective tissue—abdominal aortic aneurysm	0.00555	0.011	CbGeAlD
Ponatinib—KIT—kidney—abdominal aortic aneurysm	0.00542	0.0107	CbGeAlD
Ponatinib—PDGFRA—spinal cord—abdominal aortic aneurysm	0.00528	0.0104	CbGeAlD
Ponatinib—SRC—spinal cord—abdominal aortic aneurysm	0.00518	0.0102	CbGeAlD
Ponatinib—KDR—spinal cord—abdominal aortic aneurysm	0.00477	0.00942	CbGeAlD
Ponatinib—ABL1—kidney—abdominal aortic aneurysm	0.00472	0.00933	CbGeAlD
Ponatinib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00458	0.00904	CbGeAlD
Ponatinib—CYP2D6—blood plasma—abdominal aortic aneurysm	0.0045	0.0089	CbGeAlD
Ponatinib—KIT—spinal cord—abdominal aortic aneurysm	0.00422	0.00835	CbGeAlD
Ponatinib—ABL1—spinal cord—abdominal aortic aneurysm	0.00368	0.00727	CbGeAlD
Ponatinib—ABCB1—blood plasma—abdominal aortic aneurysm	0.00324	0.0064	CbGeAlD
Ponatinib—CYP2C8—kidney—abdominal aortic aneurysm	0.00306	0.00605	CbGeAlD
Ponatinib—CYP3A5—kidney—abdominal aortic aneurysm	0.00276	0.00546	CbGeAlD
Ponatinib—ABCG2—spinal cord—abdominal aortic aneurysm	0.00232	0.00458	CbGeAlD
Ponatinib—CYP3A4—kidney—abdominal aortic aneurysm	0.00207	0.0041	CbGeAlD
Ponatinib—CYP2D6—kidney—abdominal aortic aneurysm	0.00204	0.00403	CbGeAlD
Ponatinib—ABCB1—kidney—abdominal aortic aneurysm	0.00147	0.0029	CbGeAlD
Ponatinib—ABCB1—spinal cord—abdominal aortic aneurysm	0.00114	0.00226	CbGeAlD
Ponatinib—FGFR1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000337	0.000682	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000335	0.000677	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000334	0.000676	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000329	0.000667	CbGpPWpGaD
Ponatinib—LCK—Immune System—AAAS—abdominal aortic aneurysm	0.000328	0.000664	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000328	0.000663	CbGpPWpGaD
Ponatinib—LYN—Immune System—NCF1—abdominal aortic aneurysm	0.000327	0.000662	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000327	0.000661	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000326	0.000661	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NCF1—abdominal aortic aneurysm	0.000325	0.000659	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000325	0.000657	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—LDLR—abdominal aortic aneurysm	0.000325	0.000657	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000323	0.000654	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—NOS2—abdominal aortic aneurysm	0.000322	0.000651	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—NOS2—abdominal aortic aneurysm	0.00032	0.000648	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.00032	0.000647	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000317	0.000642	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000316	0.00064	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000315	0.000637	CbGpPWpGaD
Ponatinib—FGFR4—Disease—SERPINE1—abdominal aortic aneurysm	0.000314	0.000636	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000312	0.000632	CbGpPWpGaD
Ponatinib—SRC—Disease—LRP1—abdominal aortic aneurysm	0.000309	0.000625	CbGpPWpGaD
Ponatinib—LCK—Disease—AAAS—abdominal aortic aneurysm	0.000303	0.000613	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000301	0.000609	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000299	0.000605	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000298	0.000603	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—MMP9—abdominal aortic aneurysm	0.000296	0.0006	CbGpPWpGaD
Ponatinib—FGFR3—Disease—APOE—abdominal aortic aneurysm	0.000296	0.0006	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000295	0.000597	CbGpPWpGaD
Ponatinib—SRC—Immune System—AAAS—abdominal aortic aneurysm	0.00029	0.000588	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000286	0.000579	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP2—abdominal aortic aneurysm	0.000286	0.000579	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000284	0.000574	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000281	0.000569	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00028	0.000568	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.00028	0.000567	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000279	0.000564	CbGpPWpGaD
Ponatinib—FGFR3—Disease—NOS2—abdominal aortic aneurysm	0.000276	0.000559	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000276	0.000558	CbGpPWpGaD
Ponatinib—FGFR4—Disease—PTGS2—abdominal aortic aneurysm	0.000274	0.000555	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000271	0.000548	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000271	0.000548	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00027	0.000547	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00027	0.000546	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000268	0.000543	CbGpPWpGaD
Ponatinib—SRC—Disease—AAAS—abdominal aortic aneurysm	0.000268	0.000543	CbGpPWpGaD
Ponatinib—LCK—Immune System—NCF1—abdominal aortic aneurysm	0.000268	0.000542	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000266	0.000537	CbGpPWpGaD
Ponatinib—LCK—Disease—LDLR—abdominal aortic aneurysm	0.000264	0.000535	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—NOS2—abdominal aortic aneurysm	0.000264	0.000534	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000262	0.000531	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000259	0.000523	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—NFKB1—abdominal aortic aneurysm	0.000258	0.000522	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000258	0.000522	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000257	0.00052	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000256	0.000518	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000253	0.000512	CbGpPWpGaD
Ponatinib—LCK—Disease—NCF1—abdominal aortic aneurysm	0.000247	0.000501	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AAAS—abdominal aortic aneurysm	0.000246	0.000497	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000244	0.000495	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.00024	0.000486	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00024	0.000486	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00024	0.000485	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000239	0.000484	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000238	0.000481	CbGpPWpGaD
Ponatinib—SRC—Immune System—NCF1—abdominal aortic aneurysm	0.000237	0.00048	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000237	0.000479	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000236	0.000477	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000235	0.000476	CbGpPWpGaD
Ponatinib—SRC—Disease—LDLR—abdominal aortic aneurysm	0.000234	0.000474	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000234	0.000473	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—NOS2—abdominal aortic aneurysm	0.000233	0.000472	CbGpPWpGaD
Ponatinib—FGFR3—Disease—SERPINE1—abdominal aortic aneurysm	0.000232	0.000471	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000229	0.000463	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000226	0.000457	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000225	0.000456	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000222	0.000449	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000221	0.000448	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000221	0.000448	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00022	0.000445	CbGpPWpGaD
Ponatinib—SRC—Disease—NCF1—abdominal aortic aneurysm	0.000219	0.000443	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000216	0.000438	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000216	0.000438	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP9—abdominal aortic aneurysm	0.000215	0.000435	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.000215	0.000434	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000212	0.00043	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000212	0.000429	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000211	0.000428	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000211	0.000428	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.00021	0.000426	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.00021	0.000425	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000209	0.000424	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000209	0.000423	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000208	0.000422	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000207	0.00042	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000207	0.000419	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000204	0.000413	CbGpPWpGaD
Ponatinib—FGFR2—Disease—APOE—abdominal aortic aneurysm	0.000204	0.000412	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000203	0.000411	CbGpPWpGaD
Ponatinib—FGFR3—Disease—PTGS2—abdominal aortic aneurysm	0.000203	0.000411	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000202	0.00041	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000202	0.000408	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000201	0.000407	CbGpPWpGaD
Ponatinib—KIT—Disease—APOE—abdominal aortic aneurysm	0.0002	0.000405	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000196	0.000398	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000193	0.00039	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000192	0.000389	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000192	0.000389	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—NFKB1—abdominal aortic aneurysm	0.000191	0.000386	CbGpPWpGaD
Ponatinib—FGFR1—Disease—APOE—abdominal aortic aneurysm	0.00019	0.000384	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NOS2—abdominal aortic aneurysm	0.00019	0.000384	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—APOE—abdominal aortic aneurysm	0.000189	0.000383	CbGpPWpGaD
Ponatinib—KIT—Disease—NOS2—abdominal aortic aneurysm	0.000186	0.000377	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000185	0.000375	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000185	0.000374	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000184	0.000373	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000184	0.000373	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000184	0.000372	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000181	0.000367	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000181	0.000366	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000177	0.000359	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NOS2—abdominal aortic aneurysm	0.000177	0.000358	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NOS2—abdominal aortic aneurysm	0.000176	0.000357	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.000176	0.000356	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000174	0.000353	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000173	0.000351	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000172	0.000348	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—AGT—abdominal aortic aneurysm	0.000172	0.000347	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000171	0.000347	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00017	0.000343	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000169	0.000341	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—APOE—abdominal aortic aneurysm	0.000168	0.00034	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000167	0.000338	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000164	0.000332	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000163	0.000329	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SERPINE1—abdominal aortic aneurysm	0.00016	0.000324	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000158	0.00032	CbGpPWpGaD
Ponatinib—KIT—Disease—SERPINE1—abdominal aortic aneurysm	0.000157	0.000318	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000155	0.000313	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.000154	0.000311	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000153	0.000311	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000153	0.00031	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.000153	0.000309	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000152	0.000307	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000152	0.000307	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000151	0.000307	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000151	0.000306	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SERPINE1—abdominal aortic aneurysm	0.000149	0.000302	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SERPINE1—abdominal aortic aneurysm	0.000149	0.000301	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000146	0.000295	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000145	0.000294	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000143	0.000289	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000143	0.000289	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000142	0.000287	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00014	0.000284	CbGpPWpGaD
Ponatinib—FGFR2—Disease—PTGS2—abdominal aortic aneurysm	0.00014	0.000283	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000139	0.000282	CbGpPWpGaD
Ponatinib—KIT—Disease—PTGS2—abdominal aortic aneurysm	0.000137	0.000278	CbGpPWpGaD
Ponatinib—LCK—Disease—APOE—abdominal aortic aneurysm	0.000137	0.000277	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000136	0.000275	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000135	0.000274	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000134	0.000271	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000133	0.00027	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000133	0.000269	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000133	0.000269	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000133	0.000268	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NFKB1—abdominal aortic aneurysm	0.000131	0.000266	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTGS2—abdominal aortic aneurysm	0.00013	0.000263	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTGS2—abdominal aortic aneurysm	0.00013	0.000263	CbGpPWpGaD
Ponatinib—KIT—Immune System—NFKB1—abdominal aortic aneurysm	0.000129	0.000261	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000129	0.000261	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS2—abdominal aortic aneurysm	0.000128	0.000258	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.000125	0.000253	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000125	0.000252	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000124	0.000251	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000123	0.00025	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000123	0.000249	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NFKB1—abdominal aortic aneurysm	0.000122	0.000248	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NFKB1—abdominal aortic aneurysm	0.000122	0.000247	CbGpPWpGaD
Ponatinib—SRC—Disease—APOE—abdominal aortic aneurysm	0.000121	0.000245	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00012	0.000243	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000119	0.000242	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000118	0.000238	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000117	0.000237	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000116	0.000235	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—abdominal aortic aneurysm	0.000115	0.000233	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	0.000113	0.00023	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—abdominal aortic aneurysm	0.000113	0.000229	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000112	0.000227	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000112	0.000226	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000111	0.000226	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	0.000111	0.000225	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00011	0.000223	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00011	0.000222	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.000109	0.000221	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000109	0.00022	CbGpPWpGaD
Ponatinib—LYN—Immune System—NFKB1—abdominal aortic aneurysm	0.000108	0.000218	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000107	0.000218	CbGpPWpGaD
Ponatinib—LCK—Disease—SERPINE1—abdominal aortic aneurysm	0.000107	0.000218	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NFKB1—abdominal aortic aneurysm	0.000107	0.000217	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000106	0.000215	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000104	0.000211	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000104	0.000211	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.83e-05	0.000199	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AGT—abdominal aortic aneurysm	9.79e-05	0.000198	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APOE—abdominal aortic aneurysm	9.59e-05	0.000194	CbGpPWpGaD
Ponatinib—SRC—Disease—SERPINE1—abdominal aortic aneurysm	9.51e-05	0.000193	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—abdominal aortic aneurysm	9.38e-05	0.00019	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.18e-05	0.000186	CbGpPWpGaD
Ponatinib—LCK—Immune System—NFKB1—abdominal aortic aneurysm	8.82e-05	0.000179	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AGT—abdominal aortic aneurysm	8.66e-05	0.000175	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.58e-05	0.000174	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APOE—abdominal aortic aneurysm	8.49e-05	0.000172	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.48e-05	0.000172	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.42e-05	0.00017	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.33e-05	0.000169	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—abdominal aortic aneurysm	8.31e-05	0.000168	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	8.19e-05	0.000166	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	8.12e-05	0.000164	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.06e-05	0.000163	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.99e-05	0.000162	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.97e-05	0.000161	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	7.96e-05	0.000161	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.91e-05	0.00016	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.89e-05	0.00016	CbGpPWpGaD
Ponatinib—SRC—Immune System—NFKB1—abdominal aortic aneurysm	7.81e-05	0.000158	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	7.61e-05	0.000154	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.52e-05	0.000152	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	7.15e-05	0.000145	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.14e-05	0.000144	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	7.04e-05	0.000142	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.03e-05	0.000142	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.96e-05	0.000141	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	6.89e-05	0.00014	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.66e-05	0.000135	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	6.13e-05	0.000124	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	6.01e-05	0.000122	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	5.78e-05	0.000117	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.76e-05	0.000117	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.7e-05	0.000115	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	5.66e-05	0.000115	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	5.45e-05	0.00011	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.1e-05	0.000103	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.05e-05	0.000102	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	4.72e-05	9.56e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	4.12e-05	8.33e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	3.88e-05	7.85e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	3.78e-05	7.65e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	3.7e-05	7.49e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.54e-05	5.13e-05	CbGpPWpGaD
